Related Experiment Videos

A Modular High-Throughput In Vivo Screening Platform Based on Chimeric Bacterial Receptors

Christina E Lehning1, Jan B Heidelberger2, John Reinhard3

  • 1Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark , Building 220, Kemitorvet, DK-2800, Kgs. Lyngby, Denmark.

ACS Synthetic Biology
|April 5, 2017
PubMed
Summary

This study presents a novel screening platform using chimeric receptors in E. coli to find new antibacterials targeting multidrug resistance (MDR). The system rapidly screens compound libraries for molecules that modulate bacterial two-component systems.

Related Concept Videos